INTRODUCTION
============

Success in implant therapy demands a balance between biological and mechanical factors^[@r11]^. Failures in these procedures have been associated with a lack of stability or a misfit at the implant/abutment (I/A) interface^[@r01],[@r11],[@r28]^. External hexagon (EH) implants *ad modum* Branemark present an acceptable amount of bone loss around the I/A interface. This bone loss is considered to be normal at approximately 1.0 mm for the first year of function and 0.2 mm thereafter^[@r01]^. The I/A interface is correlated with the presence of bacterial infiltration and inflammatory cells that can lead to bone loss around this area^[@r05],[@r06],[@r15],[@r17],[@r27]^.

The amount of bacterial infiltration between the implants and abutments depends on factors such as the fit accuracy between the pieces and the tightening torque and micro-movements between the connected components during mastication^[@r07],[@r19],[@r24],[@r28],[@r30]^. Preventing bacterial infiltration at the I/A interface was a challenge that was pursued during the development of two-stage implants. The goal was to minimize the inflammatory reaction and therefore maintain the bone around the implant top^[@r09],[@r25]^. Implant companies attempt to reduce this bacterial infiltration by increasing the accuracy and stability of the jointed parts through the fabrication of mechanical pieces with a high degree of precision^[@r09],[@r25],[@r26]^.

The I/A interface in EH implants is reported as being more favorable to the infiltration of fluids than other joints^[@r04],[@r10],[@r14],[@r16],[@r18],[@r23],[@r26],[@r29]^. The microgap in this implant design varies from 1 to 49 µm, depending on the type of abutment that is selected^[@r07],[@r14]^. It represents a risk for plaque accumulation that favors bacterial aggregation^[@r03],[@r14],[@r19]-[@r22],[@r24],[@r26],[@r28],[@r30]^. *In vitro* studies on bacterial infiltration have used different species of bacteria with sizes that vary from 1 to 10 µm^[@r03],[@r04],[@r09],[@r10],[@r12],[@r14],[@r16],[@r19]-[@r21],[@r23],[@r24],[@r26],[@r29],[@r30]^. Toxins and stains^[@r04],[@r08],[@r13]^ from these bacteria^[@r14]^ have also been used and are even smaller. *Escherichia coli* is a facultative anaerobic bacteria that ranges from 1.1 to 1.5 µm in diameter. It has great motility and has been widely used in similar implant-related studies such as this one^[@r16],[@r30]^.

Several methodologies have been used to evaluate the magnitude of this microgap at the I/A interface as well as its real influence in the bacterial infiltration process^[@r09],[@r14],[@r16],[@r26],[@r29]^. Bacterial infiltration has been evaluated in a two-way path, not only from inside the screw role to the outside (I/E)^[@r03],[@r04],[@r08],[@r12]-[@r14],[@r16],[@r19],[@r30]^, but also inward from the outer part of the implant (E/I)^[@r04],[@r09],[@r10],[@r12],[@r20],[@r23],[@r26]^. The results have been evaluated through qualitative methods of turbidity of nutrient broths^[@r04],[@r12],[@r14],[@r16],[@r19],[@r23],[@r24],[@r30]^ and quantitative methods of analyzing bacterial DNA^[@r03],[@r10],[@r21]^. Nonetheless, all methods have several critical points that can either lead to false positive or false negative results. Some of these points include holding the implant with forceps; free-hand inoculation of the bacterial suspension inside the implant; sealing the entire implant by favoring fluids that flow inside the interface; using a single torquemeter for all samples; failing to determine the area inside the implant so that the right amount of bacterial suspension can be used; the type of bacteria and its viability within the study conditions and the sterile technique that is used when studying the inward flow from the outer part of the implant. This lack of standardization in the methodology leads to a large amount of variability in the results observed in these studies^[@r29]^.

The lack of standardized knowledge about this microgap and its influence in the bacterial colonization and proliferation makes it difficult to provide information about the flow of fluids between the inner and outer parts of the I/A interface^[@r08]^. The hypothesis was that not only the volume of bacteria inoculated inside the internal cavity of the implant but also the tightening torque of the abutment screw influence bacterial microleakage in non-loading conditions. Therefore, the aim of this study was to evaluate the role of different abutment tightening torques in microleakage at the I/A interface in EH implants *ad modum* Brånemark in static conditions.

MATERIAL AND METHODS
====================

Twenty-seven EH and external torque screw-type cylindrical implants (3.75x11 mm) and conical abutments (4.1 mm platform and 4.0 mm trans-mucosal height - NEODENT^®^, Curitiba, SP, Brazil) were used in this study. During the first phase, the ideal volume of the bacterial suspension to be inoculated inside the implant was evaluated. This volume was then used in the second phase to evaluate the effect of the tightening torque ([Figure 1](#f01){ref-type="fig"}).
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*Escherichia coli* bacteria (ATCC 35218) was cultivated in brain heart infusion broth - BHI (Biolife, Milan, Italy) in an incubator (BIOMATIC, Porto Alegre, RS, Brazil) for 24 hrs at 37ºC and used in this experiment. All of the instruments that were used were autoclaved at 121ºC at 15 psi for 15 minutes.

For the first phase, nine I/A sets were randomly inoculated with different volumes of bacterial suspension and divided into three groups (n=3): V0.5 - 0.5 µL; V1.0 - 1.0 µL and V1.5 - 1.5 µL ([Figure 1](#f01){ref-type="fig"}). All of the procedures and necessary materials were conducted under clean conditions of a laminar flow hood (VECO, Campinas, Brazil). A standard bacterial suspension dilution of 0.5 McFarland (10^[@r08]^ colony forming unit/mL - CFU/mL) was prepared and taken to the hood. Micro-centrifuge tubes (Eppendorf, Enfield, USA) were filled with 140 µL of BHI by using an automatic pipette (20-200 µL, LABMATE+, HT-High Tech Laboratories, PZ HTL S.A, Warsaw, Poland). The implants were set on a holder and swabbed to evaluate the sterile condition. The swabs were also kept in BHI. An automatic pipette (0.1-20 µL, LABMATE+, HT-High Tech Laboratories, PZ HTL S.A, Warsaw, Poland) was fixed to the vertical shaft of a dental surveyor (BIOART, São Carlos, SP, Brazil) ([Figure 2](#f02){ref-type="fig"}). The stabilized pipette allowed inoculating the amount that was necessary for each experimental group inside the implant internal cavity (screw channel).
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After the implant, the internal cavity was inoculated, the abutment was opened and carefully installed by using sterile pliers. It was then tightened to 20 Ncm torque, according to the manufacturer\'s recommendations, with a manual torquemeter that was individually calibrated for each sample. For the torque to be applied, the implant was kept in the implant holder ([Figure 2E](#f02){ref-type="fig"}). The implant holder was manually stabilized during the torque. A new swab was obtained from the I/A interface to assure that no leakage or overflow of the bacterial suspension had occurred during the abutment installation and screw tightening process. After inoculation, all of the implant/abutment samples and swabs were kept in sterile BHI broth. The tubes with implants and swabs were maintained in an incubator at 37ºC for up to 14 days in order to evaluate the bacterial infiltration at the I/A interface.

The swabs for contamination control were evaluated after 24h by changes in the broth\'s turbidity. A turbid broth indicated bacterial leakage during the inoculation and/or abutment installation and that sample would be excluded. The implant/abutment samples were also evaluated every 24 h by the same method to evaluate the bacterial microleakage at the I/A interface.

For the second phase, the materials and I/A sets that were used in the first phase were autoclaved as previously mentioned. Twenty-seven implant/abutment sets were randomly divided into three groups (n=9). Each group received a different tightening torque: T10: 10 Ncm; T20: 20 Ncm and T32: 32 Ncm. The amount of solution to be inoculated according to the first phase of this study was set to 0.5 µL *E. coli* solution at a 0.5 McFarland density. The protocol for inoculation, contamination control and incubation was maintained the same as the first phase. After 14 days, if no bacterial growth was observed, the I/A samples were opened in the laminar flow hood. After both phases of this study, the disassembled components were placed in a new tube with sterile BHI to verify the viability of the bacteria ([Figure 3](#f03){ref-type="fig"}). If the bacteria were not viable after this period, the sample would be excluded to prevent a false negative result.
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For the statistical analysis, comparison of microleakage among the groups was performed by the Kruskal-Wallis test. The significance level was set at p\<0.05.

RESULTS
=======

First phase
-----------

After 24 h, all of the swabs obtained from the I/A interfaces after abutment installation for groups V1.0 and V1.5 presented bacterial growth, which was assessed by the turbidity of the BHI broth in these swabs. It demonstrated the overflow of the bacterial suspension. Therefore, for the second phase, 0.5 µL of bacterial solution was selected for the type of implant that was used in this study.

Second phase
------------

After 24 h, one of the T20 group samples presented contamination by evaluation of the swab after the abutment installation; thus, it was excluded. During the first 24 h, two samples from group T10 (20%) and one sample from group T20 (10%) presented bacterial growth and turbidity of the BHI broth, indicating bacterial microleakage. No samples from the T32 group presented bacterial microleakage. During 14 days, none of the other samples presented signs of bacterial microleakage. No statistically significant differences among the groups were observed (p\<0.05). After the 14-day period, the I/A samples were opened and the bacterial viability was confirmed in all the samples ([Figure 3](#f03){ref-type="fig"}).

DISCUSSION
==========

Microleakage at the I/A interface in different implant systems has been evaluated by using methods with bacteria^[@r03],[@r04],[@r07],[@r10],[@r12],[@r16],[@r20],[@r21],[@r23],[@r24],[@r28],[@r30]^, their toxins^[@r29]^, and even dyes^[@r08],[@r13],[@r23]^. However, the results demonstrate great variability, suggesting that some limitations in these designs exist, hindering its reproducibility.

Microbiological studies, in general, are very sensitive due to the handling of biological agents. These biological agents are susceptible to changes in the working and storage environment. It is even more critical when that environment has limitations in terms of the size and source of nutrition and oxygen for the microorganism, as is the case within the implant internal cavity. It is important to adopt procedures to minimize the possibility of operator-related mistakes. It is also vital to establish a methodology that allows reproducible results among different researchers, which makes it possible to compare microleakage at the I/A interfaces of different implant systems^[@r29]^. In this study, special care was taken to keep the samples sterile and prevent contamination during inoculation by taking swabs of the external surfaces of each sample throughout the experiment. These procedures could guarantee that the only factor accounting for turbidity of the broth would be related to bacteria migrating from the implant internal cavity.

Some of the studies that evaluate the microleakage at the I/A interface use forceps to hold the implants when inoculating the bacteria and seating the abutments^[@r03],[@r04],[@r09],[@r12],[@r14],[@r16],[@r19],[@r21]^. This procedure is frequently carried out with free-hand inoculation of the bacteria^[@r03],[@r04],[@r08],[@r09],[@r12]-[@r14],[@r16],[@r19],[@r21],[@r29],[@r30]^. The implant internal cavity has a 2-3 mm opening, which is a very tight space that requires a high level of operator precision when inoculating the bacteria. Coming into contact with the implant internal cavity opening could lead to false positive results by facilitating the bacteria\'s migration to the outside. The use of excessive force with the forceps close to the implant platform could also distort the titanium implant^[@r02]^, which increases the gap at the I/A interface and favors bacterial migration. Based on these facts, two devices have been developed for this study. The first is intended to firmly hold the implant at its apical portion and prevent distortion of the coronal aspect. The second is a pipette carrier that holds the pipette in a stable position in order to prevent the samples from becoming contaminated ([Figure 2](#f02){ref-type="fig"}).

Because there are several different implant systems, different amounts of bacterial suspension have been used to inoculate the implants in microleakage studies^[@r03],[@r04],[@r09],[@r12],[@r14],[@r16],[@r19]-[@r22],[@r29],[@r30]^. The amount of material that is added to the implant internal cavity can influence bacterial leakage as it could express during the abutment placement. Therefore, the internal volume must be determined when designing these experiments. To minimize the risk of using excess material, the first step of the study was to evaluate the amount of bacterial suspension that would fit our specific implant design. The analysis of the turbidity of the broth with the cotton swabs from the outer part of the I/A interface after the abutment installation demonstrated bacterial leakage for groups V1.0 and V1.5 after 24 h. Thus, a 0.5-µL-bacterial suspension was used for the second part of this study.

The implants were covered up to the I/A interface^[@r04],[@r09],[@r12],[@r14],[@r16],[@r19],[@r30]^ to eliminate the flow of microorganisms at the abutment/screw interface, as has been observed in a previous study^[@r24]^, and also to eliminate the use of sealing materials^[@r03],[@r04],[@r19],[@r21],[@r23],[@r30]^. This study used abutments with a 4 mm-high gingival collar to separate the abutment/screw interface from the BHI broth.

The bacterium that was used in this study was *E. coli*. It is a gram-negative, rod-shaped, facultative anaerobic bacterium that ranges from 1.1 to 1.5 µm in diameter and 2 to 6 µm in length. It exhibits a high degree of motility^[@r16],[@r30]^ and survival in adverse environments. This bacterium was selected because of its ability to survive the study conditions since the implant internal cavity would have a limited supply of oxygen and nutrients for 14 days. *In vitro* studies that use round bacteria reported that most of the microleakage occurred in the first couple of days^[@r03],[@r12],[@r16],[@r21]^. The same trend was also observed in this study, which could be due to the reduction of the amount of nutrients in the medium. It also suggests that a longer incubation time could lead to the death of the bacteria. After a 14-day follow-up, the bacteria inside the implant internal cavity were proven to be viable and able to expand after 24 h. Some studies that did not check the bacterial viability could obtain misleading conclusions regarding the microleakage at the I/A interface^[@r09]^. Microleakage that occurs only during the first couple of days reinforces the hypothesis that the conditions inside the implant\'s internal cavity become extremely adverse to bacterial survival, growth, and movement through the I/A interface. A control group for this type of study would be a group that would always lead to microleakage even at the 0.5 µL volume by keeping a gap at the I/A interface. However, in this study no control group was selected because the idea was to evaluate the microleakage with different amounts of bacterial solution and different tightening torques.

Even though two of the I/A assemblies that were tightened to 10 Ncm and one tightened to 20 Ncm torque showed bacterial leakage at the I/A interface, a statistical evaluation did not show any difference among the different tightening torque groups. Bacterial leakage was not observed in the 32 Ncm tightening torque group. Within these study conditions, torque tightening did not statistically affect the microleakage at the I/A interface and contrasts with a different study that used dyes^[@r13]^. In this study, the EH connection showed a low incidence of bacterial leakage at the I/A interface, which was also a finding that differed from previous studies^[@r03],[@r10],[@r19],[@r21]^.

Based on the recent *in vitro* bacterial microleakage studies^[@r03],[@r09],[@r19]-[@r21]^ one limiting factor in this study was the fact that we did not use cyclic loading. Even though there have been indications that with cyclic loading the microgap can increase and facilitate the flow of fluids, primarily in EH designs^[@r27],[@r28],[@r30]^. Harder and cowokers^[@r14]^ in 2010 reported that more stable connections, such as a internal conical with a microgap of approximately 2-4 µm, could allow the flow of toxins of minute sizes. These toxins come from the bacterial cell wall and are mainly responsible for the bone loss in the area^[@r18]^ It suggests that the bone loss is more related to the distance from the interface to the bone^[@r17]^ than to the bacterial flow in the area^[@r06],[@r15],[@r16]^. This study aimed in calculating the ideal amount of fluids that could be inoculated inside the implant internal cavity without leading to false positive or false negative results. This study also tried to validate a device that could allow adequate inoculation of the material without contaminating the external surface of the implant and abutment. Despite that, the results of this study indicate that in static conditions, implants with a 32 Ncm tightening torque do not allow bacterial microleakage at the I/A interface.

*In vitro* studies with microorganisms have some difficulties that are related to handling, due to the size of the implants and the challenge in maintaining sterile conditions throughout the experiment. It is also difficult to measure the amount of leakage that is detected at the interface and to conduct long-term experiments with viable amounts of bacteria. Nevertheless, additional studies should be conducted to evaluate the bacterial microleakage as well as that of its toxins. These experiments should be conducted in different implant systems and in different loading conditions to better evaluate the importance of the microgap on bacterial microleakage.

The present study reinforces the importance of using different amounts of bacterial suspension for different implant systems, procedures for handling the implants and inoculating the bacteria, and also to check for the overflow of bacterial suspension and viability. Since this study did not use dyes that contain particles of approximately the same size as bacterial toxins and are related to bone loss, or cyclic loading, which can interfere with microleakage, it is imperative to conduct additional studies to address these issues.

CONCLUSION
==========

Within the limitations of this study, it was concluded that the tightening torque did not statistically influence bacterial microleakage at the I/A interface of EH implants. Nonetheless, only the samples that were tightened to 32 Ncm failed to present any sign of bacterial contamination in static conditions. After 14 days, the bacteria in the internal cavity of the implant were proven to be viable. Regarding the amount of bacterial suspension that should be added to the implant internal cavity, this study found that 0.5 µL is the ideal amount to prevent overflow and cause false positive results. Although the *in vitro*methodology to evaluate bacterial microleakage in implants is efficient, it has some limitations, and operator-dependent variables should be minimized.
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